Myriad Genetics (MYGN) Buildings (2015 - 2019)

Myriad Genetics has disclosed Buildings across 5 years of filings, most recently posting $18.2 million for Q3 2019.

• In Q3 2019, Buildings fell 3.7% year-over-year to $18.2 million; the TTM figure through Sep 2019 stood at $18.2 million (down 3.7% YoY), while the FY2019 annual figure was $18.8 million, down 2.59% from the prior year.
• Buildings slipped to $18.2 million in Q3 2019, from $18.8 million in the prior quarter.
• Over the last five years, Buildings for MYGN reached as high as $20.5 million in Q1 2018 and fell as low as $16.1 million in Q4 2016.
• The 5-year median for Buildings is $18.2 million (2015), against an average of $18.2 million.
• Annual changes were most pronounced in 2017 — Buildings fell 13.3% — and 2018, when it gained 25.77%.
• A 5-year view of Buildings shows it stood at $17.3 million in 2015, then dropped by 6.94% to $16.1 million in 2016, then grew by 22.98% to $19.8 million in 2017, then retreated by 4.55% to $18.9 million in 2018, then dropped by 3.7% to $18.2 million in 2019.
• According to Business Quant data, Buildings over the past three periods registered $18.2 million, $18.8 million, and $18.6 million for Q3 2019, Q2 2019, and Q1 2019 respectively.